Jeffrey Pepe
Nessuna posizione attualmente
Profilo
Jeffrey C.
Pepe worked as an Attorney at MDRNA, Inc. from 2007 to 2008.
He was a Partner at Seed IP Law Group LLP from 1998 to 2004.
He was the Head of Intellectual Property at Emergent Product Development Seattle and later became the Senior Vice President & General Counsel at Silverback Therapeutics, Inc. Dr. Pepe earned a doctorate degree from the University of California, Los Angeles in 1993 and a graduate degree from Seattle University School of Law in 2000.
Precedenti posizioni note di Jeffrey Pepe
| Società | Posizione | Fine |
|---|---|---|
MDRNA, Inc.
 MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Corporate Officer/Principal | 01/04/2008 |
Seed IP Law Group LLP
 Seed IP Law Group LLP Miscellaneous Commercial ServicesCommercial Services Seed IP Law Group LLP provides legal assistance services. The private company is based in Seattle, WA. | Corporate Officer/Principal | 01/08/2004 |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
| ARS PHARMACEUTICALS, INC. | Amministratore Delegato | - |
Formazione di Jeffrey Pepe
| University of California, Los Angeles | Doctorate Degree |
| Seattle University School of Law | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
MDRNA, Inc.
MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
Seed IP Law Group LLP
Seed IP Law Group LLP Miscellaneous Commercial ServicesCommercial Services Seed IP Law Group LLP provides legal assistance services. The private company is based in Seattle, WA. | Commercial Services |
Emergent Product Development Seattle
Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Jeffrey Pepe
